Blood Transfusion Diagnostics Market Revenue to Attain USD 8.31 Bn by 2033

05 Aug 2025

Share :

Table of Content

1. Blood Transfusion Diagnostics Market Revenue and Trends 2025 to 2033 2. What are the Key Factors Boosting the Growth of the Blood Transfusion Diagnostics Market? 3. Segment Outlook 4. Regional Insights 5. Blood Transfusion Diagnostics Market Coverage 6. Blood Transfusion Diagnostics Market Key Players

Blood Transfusion Diagnostics Market Revenue and Trends 2025 to 2033

The global blood transfusion diagnostics market revenue was valued at USD 5.28 billion in 2025 and is expected to attain around USD 8.31 billion by 2033, growing at a CAGR of 5.84% during forecast period. This market is expanding due to the rising prevalence of chronic diseases, growing demand for safe blood transfusions, and advancements in diagnostic technologies.

What are the Key Factors Boosting the Growth of the Blood Transfusion Diagnostics Market?

The market for blood transfusion diagnostics is experiencing robust growth, primarily due to the rising prevalence of chronic diseases, such as cancer and kidney disease, which is boosting the demand for safe and accurate blood screening. The number of cases of infectious diseases is also rising, creating the need for robust blood screening methods, which in turn fuels the growth of the market. Additionally, the growing number of surgical procedures and trauma cases worldwide is driving greater demand for more robust transfusion diagnostics. Advancements in technology, including next-generation sequencing and automated analyzers, are enhancing detection capabilities and reducing turnaround times. Governments are also mandating reliable blood safety methods, and awareness of transfusion-transmitted infections (TTIs) is increasing, which creates immense opportunities in the market. Rising government investments in improving healthcare infrastructure in emerging economies further open up new growth avenues.

Segment Outlook

• By product type, the reagents & kits segment dominated the market in 2024, as reagents and kits are essential for accurate testing, ensuring safety and accuracy. Reagents and kits are essential in performing screening by accurately identifying blood types.
• By test type, the disease screening segment led the market for blood transfusion diagnostics in 2024, driven by the growing demand for early disease detection and prevention. The rising rates of transfusion-transmitted diseases (TTDs) and blood-borne pathogens further support segmental growth.
• By technology, the serology-based testing segment contributed the largest market share in 2024, thanks to the cost-effectiveness, accessibility, and compatibility of this technology with the most common test processes for identifying infectious diseases transmitted through transfusions.
• By end-user, the hospitals segment led the market, capturing the largest share in 2024. The dominance of hospitals stems from the availability of well-developed blood banks and integrated labs that provide safe transfusion protocols and effective testing.

Regional Insights

North America dominated the blood transfusion diagnostics market while capturing the largest share in 2024. The dominance of the region stems from its advanced healthcare system, stringent regulations regarding the safety of blood products, and the presence of advanced diagnostic centers. Rising funding for research and development programs and the increasing prevalence of blood-related diseases further bolster regional market growth.

Meanwhile, Asia Pacific is expected to grow at a rapid pace in the coming years. Ongoing improvements in healthcare infrastructure, increasing awareness of transfusion-transmitted infections, and rising demand for safe blood products are boosting the growth of the market. Moreover, increasing healthcare expenditure and the prevalence of infectious diseases are likely to contribute to market growth in the region.

Blood Transfusion Diagnostics Market Coverage

Recent Development

• In June 2025, at the 35th Regional Congress of the International Society of Blood Transfusion (ISBT) in Milan, researchers from Bengaluru, India, announced the discovery of a previously unidentified blood antigen, now named CRIB, enriching classification within the Cromer blood group system and transforming compatibility testing and transfusion safety protocols. (Source: https://m.economictimes.com)

Blood Transfusion Diagnostics Market Key Players

• Grifols, S.A.
• Ortho Clinical Diagnostics
• Bio-Rad Laboratories, Inc.
• F. Hoffmann-La Roche Ltd.
• Abbott Laboratories
• Siemens Healthineers AG
• Immucor, Inc.
• Thermo Fisher Scientific Inc.
• Quotient Limited
• Danaher Corporation (Beckman Coulter)
• Becton, Dickinson and Company (BD)
• HemoCue AB
• BioMérieux SA
• DiaSorin S.p.A
• Sysmex Corporation
• Bag Health Care GmbH
• Fresenius Kabi AG
• Gen-Probe Incorporated (Hologic)
• Agena Bioscience, Inc.
• Tulip Diagnostics (P) Ltd.

Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/6520

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com |+1 804 441 9344